In human prostate carcinoma cells, TGF-β treatment induced a rapid formation of lamellipodia through the SMAD-independent signaling pathway, which requires the activation of the Rho-family GTPases including CDC42 and RHOA (101). This evidence concerns the gene RHOA and prostate carcinoma.